ROYALTY PHARMA PLC's ticker is RPRX and the CUSIP is G7709Q104. A total of 312 filers reported holding ROYALTY PHARMA PLC in Q3 2023. The put-call ratio across all filers is 0.16 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,917,305 | +15.5% | 70,645 | +30.9% | 0.00% | 0.0% |
| Q2 2023 | $1,659,591 | +13.1% | 53,988 | +32.6% | 0.00% | 0.0% |
| Q1 2023 | $1,467,142 | -11.2% | 40,720 | -2.6% | 0.00% | 0.0% |
| Q4 2022 | $1,652,133 | +57.5% | 41,805 | +60.2% | 0.00% | 0.0% |
| Q3 2022 | $1,049,000 | -81.4% | 26,103 | -80.5% | 0.00% | -66.7% |
| Q2 2022 | $5,635,000 | +10.8% | 134,049 | +2.7% | 0.00% | +50.0% |
| Q1 2022 | $5,086,000 | -1.6% | 130,571 | +0.6% | 0.00% | 0.0% |
| Q4 2021 | $5,171,000 | +1034.0% | 129,780 | +929.2% | 0.00% | – |
| Q3 2021 | $456,000 | -97.3% | 12,610 | -97.0% | 0.00% | -100.0% |
| Q2 2021 | $16,993,000 | -65.2% | 414,553 | -63.0% | 0.01% | -70.0% |
| Q1 2021 | $48,877,000 | -12.7% | 1,120,505 | +0.2% | 0.02% | -16.7% |
| Q4 2020 | $55,966,000 | +11.7% | 1,118,204 | -6.1% | 0.02% | 0.0% |
| Q3 2020 | $50,123,000 | -3.0% | 1,191,422 | -0.7% | 0.02% | -11.1% |
| Q2 2020 | $51,684,000 | – | 1,200,000 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Siguler Guff Advisers, LLC | 3,391,754 | $92,052,204 | 47.04% |
| Indie Asset Partners, LLC | 433,000 | $11,751,620 | 11.84% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 4,095,745 | $111,158,519 | 6.01% |
| Advanced Portfolio Management, LLC | 230,000 | $6,242,200 | 5.25% |
| Compound Global Advisors, LLC | 626,412 | $17,000,822 | 3.73% |
| Geo Capital Gestora de Recursos Ltd | 135,079 | $3,666 | 3.39% |
| TORRAY INVESTMENT PARTNERS LLC | 412,633 | $11,198,860 | 1.98% |
| Overbrook Management Corp | 298,712 | $8,107,044 | 1.89% |
| Silicon Valley Community Foundation | 358,270 | $9,723,448 | 1.18% |
| Greytown Advisors Inc. | 74,601 | $2,024,671 | 1.12% |